Weekly Watch List

OCN (3/17/13, -3.85%)
GRFS (03/10/13, -0.03%)
MX (2/10/13, +10.61%)
JAH (2/3/13, +8.19%)
HCA (2/10/13, +9.16%)
PKG (3/24/13, +4.16%)
CVI (2/17/13, -8.00%)

Additions:
None

Subtractions:
CTB (3/24/13, -2.84%)
WDR (2/3/13, +8.99%)

Last week all the major U.S. indexes gained ground. The S&P 500 advanced 0.8%, the NASDAQ rose 0.7%, and the Dow and the NYSE composite each added 0.5%. The IBD outlook remains at “confirmed uptrend”. With the start of a new quarter, this week investors will be primarily focused on Friday’s employment situation report. The slow motion rally continues, keep taking what it’s giving.

This week, three watch list stocks are in a proper buy range. GRFS, trading at $29.01, found support at its ten week line and is in buy range up to $32.58. MX, trading at $17.31, is still within 5% of a $16.90 buy point off of a 1st stage flat base. HCA, trading at $40.63, broke out of a 2nd stage cup base and is still within 5% of a $39.70 buy point.

/as usual, your mileage may vary, always do your own homework

Advertisements

Weekly Watch List

GRFS (03/10/13, -2.41%)
OCN (3/17/13, -11.28%)
MX (2/10/13, +8.37%)
WDR (2/3/13, +7.27%)
JAH (2/3/13, +10.33%)
HCA (2/10/13, +5.62%)
CVI (2/17/13, -7.15%)
CTB (3/24/13, +0.00%)
PKG (3/24/13, +0.00%)

Additions:
CTB (3/24/13, +0.00%)
PKG (3/24/13, +0.00%)

Subtractions:
ABG (03/10/13, +2.38%)
CI (3/17/13, -1.41%)

Last week the major U.S. indexes mostly stumbled to the downside. The Dow ended flat, the NASDAQ dipped 0.1%, the S&P 500 slipped 0.2%, and the NYSE composite faded 0.6%. The IBD outlook remains at “confirmed uptrend”. Although the uptrend continues, the recent market action has been troubling, distribution picked up again and even the up days came on weaker volume. Until the rally either picks up steam or rolls over into correction, remain cautious. Keep playing on the long side, but watch your sell rules and never take a loss of more than 7-8% on any position.

This week, four watch list stocks are in a proper buy range. MX, trading at $16.96, is just above the $16.90 buy point of a 1st stage flat base and has also found support at its ten week line. WDR, trading at $43.09, found support at its ten week line and is in buy range up to $45.63. HCA, trading at $39.31, found support at its ten week line, is in buy range up to $41.58, and has also formed a 2nd stage flat base with a potential buy point of $39.70. PKG, trading at $43.08, found support at its ten week line and is in buy range up to $42.25.

/as usual, your mileage may vary, always do your own homework

Weekly Watch List

OCN (3/17/13, +0.00%)
GRFS (03/10/13, +4.34%)
MX (2/10/13, +7.67%)
ABG (03/10/13, +5.29%)
WDR (2/3/13, +7.57%)
JAH (2/3/13, +6.95%)
HCA (2/10/13, +1.88%)
CVI (2/17/13, -1.98%)
CI (3/17/13, +0.00%)

Additions:
CI (3/17/13, +0.00%)
OCN (3/17/13, +0.00%)

Subtractions:
BLK (2/3/13, +8.38%)
FLT (11/25/12, +34.44%)
MPC (2/3/13, +15.38%)
PKG (2/10/13, +7.45%)

Last week all the major U.S. indexes staggered to the upside. The Dow added 0.8, the NYSE composite tacked on 0.7%, the S&P 500 rose 0.6%, and the NASDAQ inched up 0.1%. The IBD outlook remains at “confirmed uptrend”. The market barely made any headway and actually picked up more distribution, not a particularly encouraging sign. This week, the FOMC meeting will be the primary focus for investors and, since the Fed is already all in as far as monetary policy goes, any potential catalyst based on news coming out of the meeting will most likely move the market to the downside. That said, for now the uptrend continues, stay long and prosper until the market tells you otherwise.

This week, two watch list stocks are in a proper buy range. HCA, trading at $37.92, found support at its ten week line, is in buy range up to $41.58, and may be forming a 2nd stage flat base with a potential buy point of $39.70. CI, trading at $62.63, found support at its ten week line and is in buy range up to $65.33.

/as usual, your mileage may vary, always do your own homework

Weekly Watch List

FLT (11/25/12, +36.38%)
GRFS (03/10/13, +0.00%)
MPC (2/3/13, +16.81%)
MX (2/10/13, +0.77%)
WDR (2/3/13, +5.50%)
BLK (2/3/13, +4.80%)
CVI (2/17/13, +5.92%)
JAH (2/3/13, +5.69%)
HCA (2/10/13, +0.08%)
PKG (2/10/13, +8.22%)
ABG (03/10/13, +0.00%)

Additions:
ABG (03/10/13, +0.00%)
GRFS (03/10/13, +0.00%)

Subtractions:
OCN (1/27/13, +8.21%)
PIR (12/30/12, +13.95%)

Last week all the major U.S. indexes marched higher. The NASDAQ vaulted 2.4%, the S&P 500 jumped 2.3%, the Dow gained 2.2%, and the NYSE composite added 2.0%. Last Tuesday’s 1.3% gain on the NASDAQ constituted a follow through day and upgraded the IBD outlook to “confirmed uptrend”. As follow through days go, this one wasn’t particularly powerful but hey, an uptrend is an uptrend. Don’t fight the tape, it’s okay to make new purchases again, ride the new rally while it lasts.

This week, two watch list stocks are in a proper buy range. HCA, trading at $37.25, found support at it’s ten week line, on good volume, and is in buy range up to $41.58. ABG, trading at $36.13, found support at it’s ten week line, on good volume, and is in buy range up to $39.58.

/as usual, your mileage may vary, always do your own homework

Weekly Watch List

FLT (11/25/12, +36.03%)
OCN (1/27/13, +7.31%)
MPC (2/3/13, +11.55%)
MX (2/10/13, -1.02%)
WDR (2/3/13, +1.74%)
PIR (12/30/12, +15.35%)
JAH (2/3/13, +3.37%)
HCA (2/10/13, -0.70%)
CVI (2/17/13, +3.15%)
BLK (2/3/13, -0.03%)
PKG (2/10/13, +3.66%)

Additions:
None

Subtractions:
AMCX (2/17/13, -4.51%)

Last week the major U.S. indexes finished mixed again. The NASDAQ gained 0.3%, the S&P 500 added 0.2%, the Dow ended flat, and the NYSE composite ticked down 0.2%. Last Monday’s negative action on volume finally broke the back of the uptrend and the IBD outlook rolled over to “market in correction”. Although the correction hasn’t been severe so far, it IS a correction, don’t try and second guess the call. Even though there were some up days last week, they came on lower volume and the declines were on higher volume, exactly the opposite action for the Bull case. Use any rally days to cast off your poor performers and be sure and lock in any gains on your winners before they turn into losses. Until the next follow through day occurs, signaling a new uptrend, raising cash is a wise strategy.

With the market in correction, none of the watch list stocks can be considered as buy candidates.

/as usual, your mileage may vary, always do your own homework

The following stocks currently exhibit potential technical characteristics consistent with historically successful shorting opportunities, emphasis on POTENTIAL:

BBBY
CXO
EMC
HAIN
MCRS
MLNX
SHLD
SINA
TIBX

INCORRECTLY SHORTING STOCKS CAN LEAD TO UNLIMITED LOSSES. Proceed at your own risk.

/How to Make Money Selling Stocks Short by William J. O’Neil